To determine whether a positive indium 111 platelet image for a left ventricular thrombus, which indicates ongoing thrombogenic activity, predicts an increased risk of systemic embolization, we compared the embolic rate in 34 patients with positive "'1In platelet images with that in 69 patients with negative images during a mean follow-up of 38±31 (+SD) months after platelet imaging. The positive and negative image groups were similar with respect to age (59± 11 vs. 62± 10 years), prevalence of previous infarction (94% vs. 78%, p<0.05), time from last infarction (28±51 vs. 33±47 months), ejection fraction (29±14 vs. 33+14), long-term or paroxysmal atrial fibrillation (15% vs. 26%), warfarin therapy during follow-up (26% vs. 20%7o), platelet-inhibitory therapy during follow-up (50% vs. 33%), injected "1'In dose (330±+92 vs.
To determine whether a positive indium 111 platelet image for a left ventricular thrombus, which indicates ongoing thrombogenic activity, predicts an increased risk of systemic embolization, we compared the embolic rate in 34 patients with positive "'1In platelet images with that in 69 patients with negative images during a mean follow-up of 38±31 (+SD) months after platelet imaging. The positive and negative image groups were similar with respect to age (59± 11 vs. 62± 10 years), prevalence of previous infarction (94% vs. 78%, p<0.05), time from last infarction (28±51 vs. 33±47 months), ejection fraction (29±14 vs. 33+14), long-term or paroxysmal atrial fibrillation (15% vs. 26%), warfarin therapy during follow-up (26% vs. 20%7o), platelet-inhibitory therapy during follow-up (50% vs. 33%), injected "1'In dose (330±+92 vs.
344±118 ,uCi), and latest imaging time (.48 hours in all patients). During follow-up, embolic events occurred in 21% (seven of 34) of patients with positive platelet images for left ventricular thrombi as compared with 3% (two of 69) of patients with negative images (p=0.002). By actuarial methods, at 42 months after platelet imaging, only 86% of patients with positive images were embolus free as compared with 98% of patients with negative images (p<0.01). To determine whether platelet imaging, which detects active thrombosis, offered additional predictive value to two-dimensional echocardiography, which is less costly and more widely available, we compared the embolic rates in 30 patients with both a positive echocardiogram and a positive platelet image to the rate in 28 patients with a positive echocardiogram but a negative platelet image. Among patients with both studies positive, embolic events occurred in 23% (seven of 30) versus 4% (one of 28) in patients with a positive echocardiogram but a negative platelet image (p=0.03). The corresponding actuarial rates at 42 months were 85% and 100% (p=O0.07). We conclude that a positive platelet image for a left ventricular thrombus predicts an increased embolic risk and appears more specific for subsequent embolization than a positive echocardiogram. Additionally, in patients with left ventricular thrombus by echocardiography, a negative platelet image predicts a low risk of subsequent embolization. These findings suggest that thrombosis imaging might be useful to assess the risk of thromboembolic complications in patients with arterial thrombosis. ( also associated with an increased embolic risk. 15 Likewise, it is unknown whether platelet imaging offers any additional predictive value regarding embolic risk beyond that available from two-dimensional echocardiography, which is more widely available and less costly. Because the major potential therapy for patients with left ventricular thrombi, warfarin, is associated with significant bleeding risks, accurate identification of patients with left ventricular thrombi who are most likely to embolize is important.
Two related hypotheses were tested in the current study. The first hypothesis was that a positive "'in platelet image for a left ventricular thrombus would predict a higher rate of subsequent embolization than a negative image. The second related hypothesis was that among a subgroup of patients who had echocardiographically documented left ventricular thrombi, a positive`1In platelet image, indicating a hematologically active thrombus, would predict a higher rate of embolization than a negative platelet image.
Methods Patient Selection
One hundred twenty-eight consecutive patients who had undergone`1In-labeled platelet imaging in 1978-1987 because of a suspected left ventricular thrombus due to either a previous anterior myocardial infarction or idiopathic cardiomyopathy were identified. Four patients with mechanical heart valves were excluded because of the known high embolic risk in such patients. An additional 21 patients were excluded because they had no follow-up information available, largely because they had been referred for platelet imaging from other institutions. The remaining 103 patients were entered. Platelet Labeling, Imaging, and Analysis 11In labeling of autologous platelets was performed with a closed blood-bag method as previously described.316 Anterior, 450 left anterior oblique, and left lateral images were obtained for 300,000 counts per view, typically at 24, 48, and 72 hours after platelet injection using a Sigma 410 Ohio Nuclear Gamma Scintillation Camera with a medium-energy parallel-hole collimator. All patients were imaged to at least 48 hours after labeled platelet injection. The mean final imaging time was 74±33 hours. The latest imaging time was 48 hours in 32 patients, 72 hours in 56 patients, and at least 96 hours in 15 patients. Both the 173 and 247 keV y-photon peaks of 1`1In were counted and recorded on Polaroid trilens film (Polaroid Corp., Cambridge, Massachusetts). Unprocessed images were interpreted by a single observer who was blinded to all clinical and echocardiographic data. A study was defined as positive when a discrete area of intracardiae activity clearly greater than background blood pool was present in at least two of the three views ( Figure 1 ). The intraobserver (88%), interobserver (100%), and test-retest (100%) reproducibility of the "In platelet imaging detection of left ventricular thrombi have been high in our laboratory. 16 Overall, 34 studies were positive for a left ventricular thrombus, and 69 were negative.
At the time of platelet imaging, most patients (81%) were receiving no antithrombotic drugs. Among the 34 patients with positive images, 25 were on no antithrombotic agents, four were receiving heparin or warfarin, and four were receiving platelet inhibitory agents. Among the 69 patients with negative images, 57 were on no antithrombotic agents, nine were receiving heparin or warfarin, and three were receiving platelet inhibitory drugs. The mean injected`11In dose was 330+92 gCi in patients witlh positive images and 344±118 gCi in patients with negative images (p=NS).
Two-dimensional Echocardiography
Two-dimensional echocardiograms were performed at the time of platelet imaging in 96 of the 103 subjects by previously described techniques.17 
Results

Patient Characteristics
Because of the selection criteria, all subjects had either a previous myocardial infarction or idiopathic cardiomyopathy (Table 1) .
Thirty-four patients had positive '1'In images for left ventricular thrombi, and 69 patients had negative images. The clinical characteristics of the two groups are listed in (Figure 2) . At 42 months after platelet imaging, 98% of patients with negative images were embolus free as compared with 86% of patients with positive images.
Comparison of Platelet Imaging and Echocardiography
Platelet imaging and echocardiographic findings in the 94 patients with technically adequate echocardiograms are compared in Table 4 . Among the 58 patients with echocardiograms interpreted as positive for a left ventricular thrombus, 52% (30 of 58) also had positive`'In platelet images.
To determine whether platelet imaging findings could stratify patients with left ventricular thrombi detected by echocardiography into low-and high-risk groups for subsequent embolization, we compared the embolic rates in patients with a positive echocardiogram and a positive indium study (n =30) with those in patients with a positive echocardiogram but a negative platelet study (n = 28). The two groups were similar with regard to most clinical features ( Table 5 ). The two groups were also similar in regard to three echocardiographic features that have been associated with an increased embolic risk, that is, thrombus protrusion, thrombus mobility, and thrombus thickness10."11314 ( Embolic Risk and Therapy of Left Ventricular Thrombi Increasing evidence indicates that patients with left ventricular thrombi are at a substantial risk of systemic embolization. In the setting of acute myocardial infarction, data regarding the embolic risk once a thrombus has formed have varied widely; however, a reasonable estimate based on the largest echocardiographic studies would be 10-20% within the first few months after infarction. 5, [7] [8] [9] [10] [11] [12] 14 In the setting of remote myocardial infarction, the risk of embolization declines; however, a recent echocardiographic study noted an embolic risk of 7% per year, which was sixfold that noted in a control group of patients without thrombi. 13 The increased risk of embolization suggests that antithrombotic therapy should be considered in patients with either acute or long-term ventricular thrombi.
The only available therapies with proven efficacy in causing thrombus resolution or in decreasing the risk of systemic emboli, however, have been heparin and warfarin. Recent small trials have suggested a reduction in embolic events by early anticoagulation7-9 in the setting of acute myocardial infarction. Additionally, four older trials of short-term anticoagulation after acute infarction, in which the presence or absence of left ventricular thrombus was unknown, documented an approximate 50% reduction in the risk of stroke in patients with myocardial infarction who were treated with anticoagulants.29 Regarding long-term thrombi, a controlled randomized trial by Tramarin et al30 noted that long-term warfarin therapy over a 1-year period caused left ventricular thrombus resolution by echocardiography in 88% of treated patients but in only 24% of controls. Addi- 
Study Limitations
This study has several limitations. In the subset analysis of the 58 subjects with positive echocardiograms, the actuarial curves between subjects with positive and negative`11In images did not reach statistical significance (p=0.07); therefore, the conclusion regarding the potential clinical use of platelet imaging in patients with positive echocardiograms is tentative. Before`11In platelet screening is adopted as a clinical tool, larger confirmatory follow-up studies should be performed. The diagnosis of a cerebral embolic event as embolic remains inexact; we used the recently described criteria of Hart et al,18 which have the benefit of greater rigor than has been applied in most previous studies. The study was retrospective and, therefore, has inherent limitations. Anticoagulation was not controlled as part of the study, although relatively small numbers of patients in both groups received warfarin or heparin. The study groups were relatively small and nonhomogeneous, and small numbers of patients with recent myocardial infarction or idiopathic cardiomyopathy were entered. Most patients (81%) in this study were receiving no antithrombotic drugs at the time of platelet labeling. Results in a population of patients receiving antithrombotic agents at the time of platelet imaging might differ because both warfarin and platelet active agents can inhibit 1`1In platelet uptake. 16 Additionally, platelet imaging does not detect all left ventricular thrombi, particularly those that are small or hematologically inactive.4,27 Because multiple platelet imaging studies during the period of follow-up were not obtained, we cannot determine if the embolic risk is reduced when the platelet image is converted from positive to negative by drugs or time.
Clinical Implications
Despite these limitations, a clear increase in clinically significant systemic emboli occurred in patients with positive platelet images. The predictive value of platelet imaging can improve the stratification of embolic risk in patients who have echocardiograms positive for left ventricular thrombi. Embolic events occurred in only 4% of patients with a positive echocardiogram but a negative platelet image; in contrast, 23% of patients with a positive echocardiogram and a positive platelet image suffered systemic emboli.
